190 related articles for article (PubMed ID: 12143238)
1. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
Kim YW; Park YK; Yoon TY; Lee SM
Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
[TBL] [Abstract][Full Text] [Related]
2. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
3. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis.
Hui AM; Li X; Shi YZ; Torzilli G; Takayama T; Makuuchi M
Hepatology; 2000 May; 31(5):1068-72. PubMed ID: 10796881
[TBL] [Abstract][Full Text] [Related]
4. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
[TBL] [Abstract][Full Text] [Related]
6. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.
Sung JY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2010 Jan; 206(1):24-9. PubMed ID: 19819644
[TBL] [Abstract][Full Text] [Related]
7. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
[TBL] [Abstract][Full Text] [Related]
8. Preneoplastic lesions in gallbladder cancer.
Roa I; de Aretxabala X; Araya JC; Roa J
J Surg Oncol; 2006 Jun; 93(8):615-23. PubMed ID: 16724345
[TBL] [Abstract][Full Text] [Related]
9. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
[TBL] [Abstract][Full Text] [Related]
13. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
[TBL] [Abstract][Full Text] [Related]
15. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis.
Chang HJ; Jee CD; Kim WH
Am J Surg Pathol; 2002 Jun; 26(6):758-66. PubMed ID: 12023580
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
18. Clinical relationship between MDR1 gene and gallbladder cancer.
Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
[TBL] [Abstract][Full Text] [Related]
19. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
